Giant cell myocarditis (GCM) is a potentially lethal subtype of myocarditis. Herein, we report a case of a 22-year-old woman with GCM who was successfully treated with prednisolone monotherapy. The patient had a fever and shortness of breath and was referred to our hospital. Laboratory test results revealed elevated troponin I levels. Cardiac magnetic resonance (CMR) showed high intensity in the inferoseptal segment of the left ventricle on T2-weighted short tau inversion recovery imaging without late gadolinium enhancement (LGE), suggesting predominant edema rather than necrosis. The patient was diagnosed with GCM based on an endomyocardial biopsy, which revealed lymphocyte infiltration and multinucleated giant cells in the absence of granuloma formation. Subsequently, the patient received intravenous methylprednisolone at 1000 mg/day for 3 days followed by oral prednisolone at 30 mg/day, which normalized troponin levels. Follow-up CMR revealed improved cardiac inflammation; therefore, the patient was discharged without prescribing another immunosuppressive agent. Prednisolone was tapered and terminated three years after discharge. The patient went one year without medication and had no recurrence of GCM on follow-up. This case highlights the presence of mild GCM, successfully treated by steroid monotherapy, in which the mismatch between high-intensity T2 areas and LGE suggests mild inflammation.
Learning objective
Giant cell myocarditis (GCM) is potentially lethal and usually requires multiple immunosuppressive agents. Here, we report a patient with GCM with preserved left ventricular ejection fraction. Cardiac magnetic resonance revealed focal high T2 signal intensity areas without late gadolinium enhancement, indicating myocardial edema without necrosis. The patient remained in remission with prednisolone monotherapy for 2 years. Our report indicates that “mild” GCM may be treated with prednisolone monotherapy.
{"title":"Complete remission of giant cell myocarditis by prednisolone monotherapy: A case with mild inflammation demonstrated by mismatch between T2-high intensity areas and late gadolinium enhancement","authors":"Takanobu Soma MD , Takahiko Kinjo MD, PhD , Shintaro Goto MD, PhD , Shingo Sasaki MD, PhD, FJCC , Hirofumi Tomita MD, PhD, FJCC","doi":"10.1016/j.jccase.2023.12.007","DOIUrl":"10.1016/j.jccase.2023.12.007","url":null,"abstract":"<div><p><span><span>Giant cell myocarditis<span><span> (GCM) is a potentially lethal subtype of myocarditis. Herein, we report a case of a 22-year-old woman with GCM who was successfully treated with prednisolone<span> monotherapy. The patient had a fever and shortness of breath and was referred to our hospital. Laboratory test results revealed elevated </span></span>troponin<span> I levels. Cardiac magnetic resonance<span> (CMR) showed high intensity in the inferoseptal segment of the left ventricle on T2-weighted short tau inversion recovery imaging without late </span></span></span></span>gadolinium enhancement (LGE), suggesting predominant edema rather than necrosis. The patient was diagnosed with GCM based on an </span>endomyocardial biopsy<span>, which revealed lymphocyte infiltration<span> and multinucleated giant cells in the absence of granuloma formation. Subsequently, the patient received intravenous methylprednisolone<span><span> at 1000 mg/day for 3 days followed by oral prednisolone at 30 mg/day, which normalized troponin levels. Follow-up CMR revealed improved cardiac inflammation; therefore, the patient was discharged without prescribing another </span>immunosuppressive agent<span>. Prednisolone was tapered and terminated three years after discharge. The patient went one year without medication and had no recurrence of GCM on follow-up. This case highlights the presence of mild GCM, successfully treated by steroid monotherapy, in which the mismatch between high-intensity T2 areas and LGE suggests mild inflammation.</span></span></span></span></p></div><div><h3>Learning objective</h3><p>Giant cell myocarditis (GCM) is potentially lethal and usually requires multiple immunosuppressive agents. Here, we report a patient with GCM with preserved left ventricular ejection fraction. Cardiac magnetic resonance revealed focal high T2 signal intensity areas without late gadolinium enhancement, indicating myocardial edema without necrosis. The patient remained in remission with prednisolone monotherapy for 2 years. Our report indicates that “mild” GCM may be treated with prednisolone monotherapy.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 182-185"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139636794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 34-year-old man with a history of Kawasaki disease had been experiencing chest pain at rest since middle school. Multidetector-row computed tomography showed no aneurysm formation; however, the right coronary artery had an anomalous origin with moderate stenosis. Invasive coronary angiography revealed moderate right coronary artery stenosis with a fractional flow reserve of 0.97. Finally, with a positive acetylcholine provocation test and elevated index of microvascular resistance, the patient was diagnosed with microvascular and epicardial vasospastic angina in the endotypes of ischemia with nonobstructive coronary arteries. This is the first reported case of both microvascular and epicardial vasospastic angina after Kawasaki disease. In patients with a history of Kawasaki disease, even those without cardiac sequelae, coronary endothelial and microvascular dysfunctions should be taken into consideration.
Learning objective
We report the first case of both microvascular and epicardial vasospastic angina in the endotypes of ischemia with nonobstructive coronary arteries after Kawasaki disease.
Coronary endothelial and microvascular dysfunctions should be taken into consideration in patients with a history of Kawasaki disease, even those without cardiac sequelae.
{"title":"Ischemia with nonobstructive coronary arteries in a patient with a history of Kawasaki disease","authors":"Ayumi Omuro MD, PhD , Tetsuya Matsuyama MD , Seigo Okada MD, PhD , Takayuki Okamura MD, PhD, FJCC","doi":"10.1016/j.jccase.2023.12.011","DOIUrl":"10.1016/j.jccase.2023.12.011","url":null,"abstract":"<div><p><span>A 34-year-old man with a history of Kawasaki disease<span> had been experiencing chest pain at rest since middle school. Multidetector-row computed tomography showed no aneurysm formation; however, the </span></span>right coronary artery<span><span> had an anomalous origin with moderate stenosis. Invasive coronary angiography<span> revealed moderate right coronary artery stenosis<span> with a fractional flow reserve of 0.97. Finally, with a positive </span></span></span>acetylcholine<span><span><span> provocation test and elevated index of microvascular resistance, the patient was diagnosed with microvascular and epicardial vasospastic angina in the endotypes<span> of ischemia with nonobstructive </span></span>coronary arteries. This is the first reported case of both microvascular and epicardial vasospastic angina after Kawasaki disease. </span>In patients<span> with a history of Kawasaki disease, even those without cardiac sequelae, coronary endothelial and microvascular dysfunctions should be taken into consideration.</span></span></span></p></div><div><h3>Learning objective</h3><p>We report the first case of both microvascular and epicardial vasospastic angina in the endotypes of ischemia with nonobstructive coronary arteries after Kawasaki disease.</p><p>Coronary endothelial and microvascular dysfunctions should be taken into consideration in patients with a history of Kawasaki disease, even those without cardiac sequelae.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 197-200"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139635575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome (ACS), which typically occurs in women at low risk of atherosclerosis. We herein report a case of SCAD in a 57-year-old man who later developed Takayasu arteritis. The patient presented to our hospital complaining of chest pain and was diagnosed with unstable angina. Emergent coronary angiography was performed, and optical coherence tomography revealed that ACS was caused by SCAD. The patient was treated medically without further ballooning or stenting. Because there was a bilateral difference in blood pressure, the systemic artery was screened by contrast-enhanced computed tomography, which showed left subclavian artery occlusion, proximal stenosis of the superior mesenteric artery, right common iliac artery dissection, and left external iliac artery dissection. Based on these results and 18F-fluorodeoxyglucose positron emission tomography findings, we diagnosed Takayasu arteritis. Prednisolone and tocilizumab were selected for medical treatment, and the patient was in a good condition at one year after the diagnosis. Takayasu arteritis can cause dissection of various arteries and should be suspected when atypical SCAD or multiple dissections are present. Early initiation of immunosuppressive therapy can control disease activity.
Learning objective
Spontaneous coronary artery dissection (SCAD) is an important cause of acute coronary syndrome. In this case, we experienced a case of SCAD which turned out to be the first symptom of Takayasu arteritis. Immunosuppressive therapy was effective for both coronary lesion and systemic vasculitis. Not only fibromuscular dysplasia, but also various types of vasculitis should therefore be considered in the differential diagnosis when encountering atypical SCAD cases.
{"title":"A case of spontaneous coronary artery dissection that later turned out to be Takayasu arteritis","authors":"Takahiro Tezuka MD , Hiroyoshi Mori MD, PhD , Hiroki Nishiwaki MD, MPH, PhD , Yosuke Takei MD , Natsuki Taira MD , Ayumi Omura MD , Daisuke Wada MD , Hiromoto Sone MD , Kazuma Tashiro MD, PhD , Tokutada Sato MD, PhD , Yoshitaka Iso MD, PhD, FJCC , Mio Ebato MD, PhD, FJCC , Hiroshi Suzuki MD, PhD, FJCC","doi":"10.1016/j.jccase.2023.12.009","DOIUrl":"10.1016/j.jccase.2023.12.009","url":null,"abstract":"<div><p><span>Spontaneous coronary artery dissection<span> (SCAD) is a rare cause of acute coronary syndrome<span> (ACS), which typically occurs in women at low risk of atherosclerosis<span><span>. We herein report a case of SCAD in a 57-year-old man who later developed Takayasu arteritis<span>. The patient presented to our hospital complaining of chest pain<span> and was diagnosed with unstable angina. Emergent </span></span></span>coronary angiography<span><span><span> was performed, and optical coherence tomography revealed that ACS was caused by SCAD. The patient was treated medically without further ballooning or stenting. Because there was a bilateral difference in blood pressure, the systemic artery was screened by contrast-enhanced </span>computed tomography<span>, which showed left subclavian artery occlusion<span>, proximal stenosis of the superior mesenteric artery, right common </span></span></span>iliac artery<span> dissection, and left external iliac artery dissection. Based on these results and </span></span></span></span></span></span><sup>18</sup><span>F-fluorodeoxyglucose positron emission tomography<span><span> findings, we diagnosed Takayasu arteritis. Prednisolone and </span>tocilizumab<span> were selected for medical treatment, and the patient was in a good condition at one year after the diagnosis. Takayasu arteritis can cause dissection of various arteries and should be suspected when atypical SCAD or multiple dissections are present. Early initiation of immunosuppressive therapy can control disease activity.</span></span></span></p></div><div><h3>Learning objective</h3><p>Spontaneous coronary artery dissection (SCAD) is an important cause of acute coronary syndrome. In this case, we experienced a case of SCAD which turned out to be the first symptom of Takayasu arteritis. Immunosuppressive therapy was effective for both coronary lesion and systemic vasculitis<span>. Not only fibromuscular dysplasia, but also various types of vasculitis should therefore be considered in the differential diagnosis when encountering atypical SCAD cases.</span></p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 186-189"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139638269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute limb ischemia (ALI) related to total knee arthroplasty (TKA) is rare. Most occlusions are caused by thrombus formation in the popliteal artery (PA). Currently such cases are revascularized using less invasive approaches such as endovascular therapy or Fogarty thrombectomy. We report a case of ALI in a 65-year-old woman with complete rupture of the PA due to a TKA procedure. She had resting pain and motor paralysis in her right lower extremity after TKA. Contrast-enhanced computed tomography showed occlusion of the right femoropopliteal artery. Subsequently, she was referred to our hospital with a diagnosis of ALI. Initially, a less invasive revascularization procedure was unsuccessfully attempted. Therefore, we performed an emergency distal bypass and succeeded in revascularization. Intraoperative examination revealed a complete rupture of the PA. Postoperatively, the patient exhibited no signs of myonephropathic metabolic syndrome. Although there was significant motor impairment, the affected limbs were successfully salvaged. ALI with complete rupture of the PA associated with TKA has not been reported previously. In cases of iatrogenic ALI after TKA, it would be essential to consider diagnostic and revascularization methods that account for the possibility of severe injury to the PA.
Learning objective
Acute limb ischemia after total knee arthroplasty is a rare and life- and limb-threatening condition. The underlying pathological mechanism is often thrombus occlusion due to mechanical stimuli of the popliteal artery (PA). There are no established treatments for this condition, and less invasive approaches such as endovascular procedures and Fogarty thrombectomy are often used. However, in cases involving severe damage to the PA, bypass surgery may be necessary, and revascularization procedures should be considered accordingly.
与全膝关节置换术(TKA)相关的急性肢体缺血(ALI)非常罕见。大多数闭塞是由腘动脉(PA)中的血栓形成引起的。目前,此类病例可通过血管内治疗或 Fogarty 血栓切除术等微创方法进行血管再通。我们报告了一例因 TKA 手术导致腘动脉完全破裂的 65 岁女性 ALI 病例。她在 TKA 术后出现静息痛和右侧下肢运动麻痹。对比增强计算机断层扫描显示她的右股骨动脉闭塞。随后,她被转诊到我院,诊断为 ALI。起初,我们尝试了一种创伤较小的血管重建手术,但没有成功。因此,我们为她实施了紧急远端搭桥术,并成功实现了血管再通。术中检查发现 PA 完全破裂。术后,患者没有肌无力代谢综合征的迹象。虽然患者的运动能力明显受损,但患肢成功获救。与 TKA 相关的 PA 完全断裂引起的 ALI 之前尚未见报道。学习目的全膝关节置换术后急性肢体缺血是一种罕见的危及生命和肢体的疾病。其基本病理机制通常是由于腘动脉(PA)受到机械刺激导致血栓闭塞。目前尚无成熟的治疗方法,通常采用血管内手术和福加蒂血栓切除术等侵入性较小的方法。但是,在腘动脉严重受损的情况下,可能需要进行搭桥手术,并应相应考虑血管再通手术。
{"title":"Iatrogenic acute limb ischemia with complete traumatic rupture of the popliteal artery associated with total knee arthroplasty","authors":"Tatsuro Takei MD , Takashi Kajiya MD , Toshiko Ninomiya MD , Keisuke Yamamoto MD , Katsuyuki Imamura MD, PhD , Nobuhiko Atsuchi MD, PhD","doi":"10.1016/j.jccase.2023.12.010","DOIUrl":"10.1016/j.jccase.2023.12.010","url":null,"abstract":"<div><p>Acute limb ischemia (ALI) related to total knee arthroplasty (TKA) is rare. Most occlusions are caused by thrombus formation in the popliteal artery (PA). Currently such cases are revascularized using less invasive approaches such as endovascular therapy or Fogarty thrombectomy. We report a case of ALI in a 65-year-old woman with complete rupture of the PA due to a TKA procedure. She had resting pain and motor paralysis in her right lower extremity after TKA. Contrast-enhanced computed tomography showed occlusion of the right femoropopliteal artery. Subsequently, she was referred to our hospital with a diagnosis of ALI. Initially, a less invasive revascularization procedure was unsuccessfully attempted. Therefore, we performed an emergency distal bypass and succeeded in revascularization. Intraoperative examination revealed a complete rupture of the PA. Postoperatively, the patient exhibited no signs of myonephropathic metabolic syndrome. Although there was significant motor impairment, the affected limbs were successfully salvaged. ALI with complete rupture of the PA associated with TKA has not been reported previously. In cases of iatrogenic ALI after TKA, it would be essential to consider diagnostic and revascularization methods that account for the possibility of severe injury to the PA.</p></div><div><h3>Learning objective</h3><p>Acute limb ischemia after total knee arthroplasty is a rare and life- and limb-threatening condition. The underlying pathological mechanism is often thrombus occlusion due to mechanical stimuli of the popliteal artery (PA). There are no established treatments for this condition, and less invasive approaches such as endovascular procedures and Fogarty thrombectomy are often used. However, in cases involving severe damage to the PA, bypass surgery may be necessary, and revascularization procedures should be considered accordingly.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 193-196"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1878540923001585/pdfft?md5=a09fd3b3be5cce2734fba5be52d280d9&pid=1-s2.0-S1878540923001585-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139538877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present three cases of hypoplastic left heart syndrome (HLHS) complicated by congenital esophageal atresia and trachea-esophageal fistula (EA/TEF). The standard treatment for HLHS involves a staged surgical approach, eventually reaching Fontan completion. There is no report of patients with both HLHS and EA/TEF, and no established treatment strategy exists for such cases. Given the significant risk of simultaneously operating on HLHS and EA/TEF, we elected to pursue staged repair for each condition separately. Initially, soon after birth, we performed gastrostomy to secure the nutritional pathway for EA/TEF and stabilize breathing. Subsequently, we conducted bilateral pulmonary artery banding (bil-PAB) and ductal stenting for HLHS, as the Norwood operation carried an unacceptably high risk in these patients. Two of these patients were able to transition to home care, while the other patient died during hospitalization due to complications after EA repair. A combination of bil-PAB with ductal stenting for HLHS and staged repair for EA/TEF may provide effective management for patients with both conditions.
Learning objective
Hypoplastic left heart syndrome (HLHS) and congenital esophageal atresia (EA) are both life-threatening conditions that require early intervention after birth. There are few reports of patients with both conditions, and no treatment strategy is established. Although the procedure carries a high risk, we successfully performed ductal stenting with bilateral pulmonary artery banding for HLHS, as well as staged repair procedures for EA. Our approach may be a viable strategy for these conditions.
我们介绍了三例并发先天性食管闭锁和气管食管瘘(EA/TEF)的左心房发育不全综合征(HLHS)病例。HLHS 的标准治疗方法包括分阶段手术,最终完成丰坦手术。目前还没有关于同时患有HLHS和EA/TEF的患者的报道,也没有针对此类病例的既定治疗策略。考虑到同时对HLHS和EA/TEF进行手术的巨大风险,我们选择分别对两种疾病进行分期修复。首先,在婴儿出生后不久,我们进行了胃造瘘术,以确保 EA/TEF 的营养途径,并稳定呼吸。随后,我们为HLHS患者进行了双侧肺动脉束扎术(bil-PAB)和肺动脉导管支架植入术,因为诺伍德手术对这些患者来说风险太高,无法接受。其中两名患者能够过渡到家庭护理,另一名患者则在住院期间因 EA 修复术后并发症而死亡。对 HLHS 采用双腔腹腔镜联合导管支架植入术,对 EA/TEF 采用分期修复术,可以有效治疗这两种疾病的患者。关于这两种疾病患者的报道很少,也没有确定的治疗策略。虽然手术风险很高,但我们成功地为HLHS患者实施了管道支架植入术和双侧肺动脉束扎术,并为EA患者实施了分期修复手术。我们的方法可能是治疗这些疾病的可行策略。
{"title":"Ductal stenting with bilateral pulmonary artery banding as a life-saving management for hypoplastic left heart syndrome with congenital esophageal atresia: A case series","authors":"Mamoru Muraoka MD , Ayako Kuraoka MD, PhD , Kenichiro Yamamura MD, PhD , Makoto Hayashida MD, PhD , Toshihide Nakano MD, PhD , Koichi Sagawa MD, PhD","doi":"10.1016/j.jccase.2023.10.012","DOIUrl":"https://doi.org/10.1016/j.jccase.2023.10.012","url":null,"abstract":"<div><p>We present three cases of hypoplastic left heart syndrome (HLHS) complicated by congenital esophageal atresia and trachea-esophageal fistula (EA/TEF). The standard treatment for HLHS involves a staged surgical approach, eventually reaching Fontan completion. There is no report of patients with both HLHS and EA/TEF, and no established treatment strategy exists for such cases. Given the significant risk of simultaneously operating on HLHS and EA/TEF, we elected to pursue staged repair for each condition separately. Initially, soon after birth, we performed gastrostomy to secure the nutritional pathway for EA/TEF and stabilize breathing. Subsequently, we conducted bilateral pulmonary artery banding (bil-PAB) and ductal stenting for HLHS, as the Norwood operation carried an unacceptably high risk in these patients. Two of these patients were able to transition to home care, while the other patient died during hospitalization due to complications after EA repair. A combination of bil-PAB with ductal stenting for HLHS and staged repair for EA/TEF may provide effective management for patients with both conditions.</p></div><div><h3>Learning objective</h3><p>Hypoplastic left heart syndrome (HLHS) and congenital esophageal atresia (EA) are both life-threatening conditions that require early intervention after birth. There are few reports of patients with both conditions, and no treatment strategy is established. Although the procedure carries a high risk, we successfully performed ductal stenting with bilateral pulmonary artery banding for HLHS, as well as staged repair procedures for EA. Our approach may be a viable strategy for these conditions.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 153-156"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140332521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Inflammatory bowel disease (IBD) is a complex chronic inflammatory intestinal disease. The development of de novo IBD after solid organ transplantation with immunosuppressive agents has been rarely reported. We present the case of a 65-year-old man with repeated colitis after heart transplantation (HTx) who was diagnosed with Crohn's disease (CD). The patient underwent HTx due to non-ischemic dilated cardiomyopathy. Six months after HTx, he developed serious diarrhea and a transient fever, which persisted for about 6 months. Valganciclovir or any antibiotic agents were not effective for his symptoms and longitudinal ulcers in colonoscopy aggravated during the course, so that we made a diagnosis of CD. We started 5-aminosalicylic acid and found improvement in his symptoms and colonoscopic findings. However, 7 months after improvement, CD worsened. We started ustekinumab by which his condition successfully went into remission again. While oral immunosuppressive drugs are thought to suppress autoimmune diseases in general, IBD should be included in the differential diagnoses for recurring enterocolitis after HTx. Poorly controlled CD can lead to serious and potentially fatal complications, but in this case, ustekinumab has been used safely and effectively for the treatment of CD.
Learning objective
Colitis is a common complication after heart transplantation (HTx). Although cytomegalovirus colitis or posttransplant lymphoproliferative disorder are observed commonly, de novo inflammatory bowel disease (IBD) should be considered when serious refractory colitis occurs. Not only 5-aminosalicylic acid but also ustekinumab, which is a monoclonal antibody to the p40 subunit of interleukin (IL)-12 and IL-23, may be a safe and effective treatment for de novo IBD after HTx.
炎症性肠病(IBD)是一种复杂的慢性肠道炎症性疾病。使用免疫抑制剂进行实体器官移植后发生新的 IBD 的报道很少。我们报告了一例心脏移植(HTx)后反复结肠炎的 65 岁男性患者,他被诊断为克罗恩病(CD)。患者因非缺血性扩张型心肌病接受了心脏移植手术。移植手术六个月后,他出现严重腹泻和一过性发热,并持续了约六个月。缬更昔洛韦或任何抗生素对他的症状都无效,结肠镜检查中的纵向溃疡在病程中加重,因此我们诊断他为 CD。我们开始使用 5-氨基水杨酸,发现他的症状和结肠镜检查结果都有所改善。然而,症状改善 7 个月后,CD 又恶化了。我们开始使用乌司他单抗(ustekinumab),他的病情再次成功缓解。虽然一般认为口服免疫抑制剂可以抑制自身免疫性疾病,但对于高热惊厥后复发的小肠结肠炎,IBD 也应纳入鉴别诊断。控制不佳的 CD 可导致严重且可能致命的并发症,但在本病例中,乌司替尼被安全有效地用于 CD 的治疗。学习目标结肠炎是心脏移植(HTx)后常见的并发症。虽然巨细胞病毒性结肠炎或移植后淋巴增生性疾病很常见,但如果出现严重的难治性结肠炎,则应考虑新生炎症性肠病(IBD)。不仅是5-氨基水杨酸,乌斯特库单抗(一种针对白细胞介素(IL)-12和IL-23的p40亚基的单克隆抗体)也可能是治疗移植后新发IBD的一种安全有效的方法。
{"title":"The first case report of de novo Crohn's disease after heart transplantation successfully treated with ustekinumab","authors":"Shun Okamura MD , Chie Bujo MD, PhD , Eisuke Amiya MD, PhD , Ken Kurokawa MD, PhD , Masaru Hatano MD, PhD, FJCC , Junichi Ishida MD, PhD , Masaki Tsuji MD, PhD , Sozaburo Ihara MD, PhD , Keita Murakami MD , Chihiro Shiomi MD , Yoku Hayakawa MD, PhD , Mitsuhiro Fujishiro MD, PhD , Minoru Ono MD, PhD, FJCC , Issei Komuro MD, PhD, FJCC","doi":"10.1016/j.jccase.2023.12.005","DOIUrl":"10.1016/j.jccase.2023.12.005","url":null,"abstract":"<div><p><span><span><span>Inflammatory bowel disease (IBD) is a complex chronic inflammatory </span>intestinal disease<span>. The development of de novo IBD after solid organ transplantation with </span></span>immunosuppressive agents<span> has been rarely reported. We present the case of a 65-year-old man with repeated colitis<span> after heart transplantation<span> (HTx) who was diagnosed with Crohn's disease (CD). The patient underwent HTx due to non-ischemic dilated cardiomyopathy. Six months after HTx, he developed serious diarrhea and a transient fever, which persisted for about 6 months. </span></span></span></span>Valganciclovir<span><span> or any antibiotic agents were not effective for his symptoms<span><span> and longitudinal ulcers in colonoscopy aggravated during the course, so that we made a diagnosis of CD. We started 5-aminosalicylic acid and found improvement in his symptoms and colonoscopic findings. However, 7 months after improvement, CD worsened. We started </span>ustekinumab by which his condition successfully went into remission again. While oral immunosuppressive drugs are thought to suppress autoimmune diseases in general, IBD should be included in the differential diagnoses for recurring </span></span>enterocolitis<span> after HTx. Poorly controlled CD can lead to serious and potentially fatal complications, but in this case, ustekinumab has been used safely and effectively for the treatment of CD.</span></span></p></div><div><h3>Learning objective</h3><p><span>Colitis is a common complication after heart transplantation (HTx). Although cytomegalovirus colitis or </span>posttransplant lymphoproliferative disorder<span> are observed commonly, de novo inflammatory bowel disease (IBD) should be considered when serious refractory colitis occurs. Not only 5-aminosalicylic acid but also ustekinumab, which is a monoclonal antibody to the p40 subunit of interleukin (IL)-12 and IL-23, may be a safe and effective treatment for de novo IBD after HTx.</span></p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 174-177"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139638179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
An 89-year-old man with symptomatic severe aortic stenosis underwent transcatheter aortic valve implantation due to old age and a history of coronary artery bypass grafting. Computed tomography showed a tricuspid aortic valve and severe calcification at the aortic valve annulus, with a perimeter of 88.7 mm. The 34-mm Evolut PRO+ (Medtronic Inc., Minneapolis, MN, USA) was selected. After balloon aortic valvuloplasty, deployment of the Evolut PRO+ was attempted, but significant expansion failure was observed. Upon retraction and removal of the Evolut PRO+ from the body, frame deformation was observed. A new Evolut PRO+ was tried again, but a similar finding was noted as a magatama-like infolding on transesophageal echocardiography. Fortunately, the patient's hemodynamics were relatively stable. Post-dilation was performed using a 25 mm Z-MED II (NuMED, Inc., Montreal, Canada) for reshaping.
Learning objective
In self-expanding transcatheter aortic valves (TAVs), bending of the TAV frame is widely known as one of the key problems. However, this is rare and infrequently encountered. In this case, TAV frame infolding occurred repeatedly, and the morphology of the infolding was evaluated in vitro and in vivo. Furthermore, we report that some TAVs can be reshaped by post-dilation.
{"title":"Infolding of Evolut PRO+ during transcatheter aortic valve implantation and bailout by post-balloon dilation: A case report","authors":"Kengo Tosaka MD, PhD, Ryo Ninomiya MD, PhD, Tetsuya Fusazaki MD, PhD, FJCC, Yoshihiro Morino MD, PhD, FJCC","doi":"10.1016/j.jccase.2023.12.008","DOIUrl":"10.1016/j.jccase.2023.12.008","url":null,"abstract":"<div><p>An 89-year-old man with symptomatic severe aortic stenosis underwent transcatheter aortic valve implantation due to old age and a history of coronary artery bypass grafting. Computed tomography showed a tricuspid aortic valve and severe calcification at the aortic valve annulus, with a perimeter of 88.7 mm. The 34-mm Evolut PRO+ (Medtronic Inc., Minneapolis, MN, USA) was selected. After balloon aortic valvuloplasty, deployment of the Evolut PRO+ was attempted, but significant expansion failure was observed. Upon retraction and removal of the Evolut PRO+ from the body, frame deformation was observed. A new Evolut PRO+ was tried again, but a similar finding was noted as a magatama-like infolding on transesophageal echocardiography. Fortunately, the patient's hemodynamics were relatively stable. Post-dilation was performed using a 25 mm <em>Z</em>-MED II (NuMED, Inc., Montreal, Canada) for reshaping.</p></div><div><h3>Learning objective</h3><p>In self-expanding transcatheter aortic valves (TAVs), bending of the TAV frame is widely known as one of the key problems. However, this is rare and infrequently encountered. In this case, TAV frame infolding occurred repeatedly, and the morphology of the infolding was evaluated in vitro and in vivo. Furthermore, we report that some TAVs can be reshaped by post-dilation.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 190-192"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139966136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-reentrant fascicular tachycardia (NRFT) developed in a 6-year-old Japanese boy. Because of drug-resistant recurrences, he received catheter mapping and ablation at age 10 years. An electrocardiogram exhibited a superior left-axis deviation, a right bundle branch block-type configuration, and relatively narrow QRS with sharp R wave. It suggested verapamil-sensitive ventricular tachycardia (VT), but showed no sensitivity to verapamil or reentrant characteristics in the electrophysiological study. Detailed VT mapping determined the earliest presystolic Purkinje potential on the left posterior fascicle at the mid-ventricular septum. Radiofrequency current applications to the lesion led to his NRFT-free life without restriction.
Learning objectives
Purkinje-related idiopathic ventricular tachycardias (VTs) are commonly due to reentrant mechanisms, and non-reentrant fascicular tachycardia (NRFT) is a rare form of idiopathic VT in adults. Although it is crucial to distinguish NRFT from reentrant VTs, there is no information about the electrophysiological studies and the treatment effect in pediatric-onset NRFT.
{"title":"Successful mapping and ablation of a pediatric-onset non-reentrant fascicular tachycardia","authors":"Yusaku Nagatomo MD, PhD , Susumu Takase MD, PhD , Kazuo Sakamoto MD, PhD , Hazumu Nagata MD, PhD , Kenichiro Yamamura MD, PhD, MSc , Hiroyuki Tsutsui MD, PhD, FJCC , Shouichi Ohga MD, PhD","doi":"10.1016/j.jccase.2023.12.002","DOIUrl":"10.1016/j.jccase.2023.12.002","url":null,"abstract":"<div><p><span>Non-reentrant fascicular tachycardia (NRFT) developed in a 6-year-old Japanese boy. Because of drug-resistant recurrences, he received catheter mapping and ablation at age 10 years. An electrocardiogram exhibited a superior left-axis deviation, a right bundle branch block-type configuration, and relatively narrow QRS with sharp </span>R wave<span><span>. It suggested verapamil-sensitive ventricular tachycardia (VT), but showed no sensitivity to </span>verapamil or reentrant characteristics in the electrophysiological study. Detailed VT mapping determined the earliest presystolic Purkinje potential on the left posterior fascicle at the mid-ventricular septum. Radiofrequency current applications to the lesion led to his NRFT-free life without restriction.</span></p></div><div><h3>Learning objectives</h3><p>Purkinje-related idiopathic ventricular tachycardias (VTs) are commonly due to reentrant mechanisms, and non-reentrant fascicular tachycardia (NRFT) is a rare form of idiopathic VT in adults. Although it is crucial to distinguish NRFT from reentrant VTs, there is no information about the electrophysiological studies and the treatment effect in pediatric-onset NRFT.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 165-169"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139193567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.1016/j.jccase.2023.10.006
Teja S. Chakrala MD , Roshni O. Prakash MD , Sahil Prasada MD , Wytch R. Rigger MD , Juan Vilaro MD
We present a case of a man with ischemic cardiomyopathy and single chamber implantable cardioverter-defibrillator who developed sinus arrest creating sudden dependence on right ventricular (RV) pacing. He presented with cardiogenic shock secondary to abrupt onset ventricular dyssynchrony from RV pacing, which required emergent stabilization and completely resolved with atrial pacing.
Learning objective
To establish a basic understanding of cardiogenic shock management. To reinforce the adverse effects associated with right ventricular pacing.
{"title":"A case of cardiogenic shock due to ventricular dyssynchrony resolved by atrial pacing","authors":"Teja S. Chakrala MD , Roshni O. Prakash MD , Sahil Prasada MD , Wytch R. Rigger MD , Juan Vilaro MD","doi":"10.1016/j.jccase.2023.10.006","DOIUrl":"https://doi.org/10.1016/j.jccase.2023.10.006","url":null,"abstract":"<div><p>We present a case of a man with ischemic cardiomyopathy and single chamber implantable cardioverter-defibrillator who developed sinus arrest creating sudden dependence on right ventricular (RV) pacing. He presented with cardiogenic shock secondary to abrupt onset ventricular dyssynchrony from RV pacing, which required emergent stabilization and completely resolved with atrial pacing.</p></div><div><h3>Learning objective</h3><p>To establish a basic understanding of cardiogenic shock management. To reinforce the adverse effects associated with right ventricular pacing.</p></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 149-152"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S187854092300124X/pdfft?md5=7add2c5c8e6611cac427f4b1762d94fc&pid=1-s2.0-S187854092300124X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140332870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A man in his 70s with a history of mitral valve replacement (MVR) and long-standing persistent atrial fibrillation (AF) presented with effort angina. Coronary angiography revealed severe stenosis of the left main coronary artery (LMCA). As it was an emergent case, PCI (percutaneous coronary intervention) was selected for treatment. Intravascular ultrasonography revealed no atherosclerotic lesions in the LMCA. The LMCA was effectively dilated by the drug-eluting stent. No elevation in intracardiac pressure was observed in cardiac catheterization after PCI. Computed tomography scan indicated potential compression of the LMCA by the surrounding structures. In cases of long-standing persistent AF and an enlarged atrium after MVR, the possibility of LMCA stenosis due to anatomical changes should be considered.
Learning Objectives
◾
Peri-valvular regurgitation and long-standing persistent atrial fibrillation can potentially cause atrial enlargement.
◾
Coronary artery stenosis without atherosclerosis can occur due to compression from surrounding structures or shifting of the coronary artery.
◾
Stent therapy provides a temporary solution and coronary artery bypass grafting or switching should be considered if re-stenosis occurs.
{"title":"A case of coronary artery compression syndrome resulting from peri-valvular regurgitation and long-standing atrial fibrillation","authors":"Keisuke Suzuki MD, PhD, Yoshiaki Mibiki MD, PhD, Mai Suzuki MD, Hiroshi Nakagata MD, PhD, Kosuke Aoki MD, Eiji Sato MD, PhD, Yoshihiro Yamashina MD, PhD, Takehiko Miyashita MD, PhD, Akihiko Ishida MD, Tetsuo Yagi MD, PhD","doi":"10.1016/j.jccase.2023.12.003","DOIUrl":"10.1016/j.jccase.2023.12.003","url":null,"abstract":"<div><p>A man in his 70s with a history of mitral valve replacement<span> (MVR) and long-standing persistent atrial fibrillation<span><span> (AF) presented with effort angina. Coronary angiography revealed severe stenosis of the left main </span>coronary artery<span><span><span> (LMCA). As it was an emergent case, PCI (percutaneous coronary intervention) was selected for treatment<span>. Intravascular ultrasonography revealed no atherosclerotic lesions in the LMCA. The LMCA was effectively dilated by the drug-eluting stent. No elevation in intracardiac pressure was observed in </span></span>cardiac catheterization<span> after PCI. Computed tomography scan<span> indicated potential compression of the LMCA by the surrounding structures. In cases of long-standing persistent AF and an enlarged atrium after MVR, the possibility of </span></span></span>LMCA stenosis due to anatomical changes should be considered.</span></span></span></p></div><div><h3>Learning Objectives</h3><p></p><ul><li><span>◾</span><span><p>Peri-valvular regurgitation and long-standing persistent atrial fibrillation can potentially cause atrial enlargement.</p></span></li><li><span>◾</span><span><p>Coronary artery stenosis without atherosclerosis can occur due to compression from surrounding structures or shifting of the coronary artery.</p></span></li><li><span>◾</span><span><p>Stent therapy provides a temporary solution and coronary artery bypass grafting or switching should be considered if re-stenosis occurs.</p></span></li></ul></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"29 4","pages":"Pages 157-160"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139395990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}